4/9
12:17 am
rigl
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade) [Seeking Alpha]
Low
Report
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade) [Seeking Alpha]
4/7
08:05 am
rigl
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3/31
08:39 am
rigl
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology [Yahoo! Finance]
Medium
Report
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology [Yahoo! Finance]
3/31
08:05 am
rigl
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Medium
Report
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
3/27
02:22 pm
rigl
Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It's Doing Better Than People Realize” [Yahoo! Finance]
Low
Report
Jim Cramer Blesses Rigel Pharmaceuticals as a Spec as “It's Doing Better Than People Realize” [Yahoo! Finance]
3/10
06:55 am
rigl
Rigel Pharmaceuticals: Growing Where It Matters [Seeking Alpha]
Low
Report
Rigel Pharmaceuticals: Growing Where It Matters [Seeking Alpha]
3/4
12:02 pm
rigl
How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress [Yahoo! Finance]
Low
Report
How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress [Yahoo! Finance]
3/4
12:15 am
rigl
Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and ... [Yahoo! Finance]
High
Report
Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and ... [Yahoo! Finance]
3/3
06:55 pm
rigl
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates [Yahoo! Finance]
Medium
Report
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates [Yahoo! Finance]
3/3
06:25 pm
rigl
Rigel Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Rigel Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
06:25 pm
rigl
Rigel Pharma (RIGL) Earnings Call Transcript [Yahoo! Finance]
High
Report
Rigel Pharma (RIGL) Earnings Call Transcript [Yahoo! Finance]
3/3
04:31 pm
rigl
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/3
04:01 pm
rigl
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/24
08:05 am
rigl
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
Low
Report
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
2/20
07:27 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/3
08:33 am
rigl
Rigel Appoints Michael P. Miller to the Board of Directors [Yahoo! Finance]
Low
Report
Rigel Appoints Michael P. Miller to the Board of Directors [Yahoo! Finance]
2/3
08:05 am
rigl
Rigel Appoints Michael P. Miller to the Board of Directors
Low
Report
Rigel Appoints Michael P. Miller to the Board of Directors
1/26
10:47 pm
rigl
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 [Seeking Alpha]
Low
Report
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 [Seeking Alpha]
1/22
07:48 am
rigl
Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "strong sell" rating.
Low
Report
Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "strong sell" rating.
1/20
11:31 am
rigl
How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow [Yahoo! Finance]
Low
Report
How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow [Yahoo! Finance]